Study of jak2 v617f mutation, serum B12 level and interleukin – 23 level in polycythemia vera

  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/views.module on line 842.
  • strict warning: Declaration of content_handler_field::options() should be compatible with views_object::options() in /home4/vibu/public_html/journalcra.com/sites/all/modules/cck/includes/views/handlers/content_handler_field.inc on line 208.
  • strict warning: Declaration of views_handler_filter::options_validate() should be compatible with views_handler::options_validate($form, &$form_state) in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/handlers/views_handler_filter.inc on line 589.
  • strict warning: Declaration of views_handler_filter::options_submit() should be compatible with views_handler::options_submit($form, &$form_state) in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/handlers/views_handler_filter.inc on line 589.
  • strict warning: Declaration of views_plugin_style_default::options() should be compatible with views_object::options() in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/plugins/views_plugin_style_default.inc on line 25.
  • strict warning: Declaration of views_plugin_row::options_validate() should be compatible with views_plugin::options_validate(&$form, &$form_state) in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/plugins/views_plugin_row.inc on line 135.
  • strict warning: Declaration of views_plugin_row::options_submit() should be compatible with views_plugin::options_submit(&$form, &$form_state) in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/plugins/views_plugin_row.inc on line 135.
  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/views.module on line 842.
  • strict warning: Declaration of views_handler_filter_boolean_operator::value_validate() should be compatible with views_handler_filter::value_validate($form, &$form_state) in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/handlers/views_handler_filter_boolean_operator.inc on line 149.
  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalcra.com/sites/all/modules/views/views.module on line 842.
Author: 
Manal Ali Abdulsahib Al-Rubaye and Abeer Anwer Ahmed
Subject Area: 
Health Sciences
Abstract: 

Introduction: Myeloproliferative neoplasms (MPNs) including Polycythemia Vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are clonal hematopoietic stem cell disorders which originate from a single stem cell. Usually one cell line predominates in a given disorder. Over the last 12 years, several somatic mutations have been described in MPN classification like: JAK2, CALR and MPL, but JAK2 is the most frequent, with frequencies of approximately 98% in PV, 50% to 60% in ET, and 55% to 65% in PMF. It is believed that cytokines participate in the activation of JAK2V617F, one of them IL-23 that acts as a pro-inflammatory mediator and can induce chronic inflammation and its plasma level increased in MPN patients. High serum cobalamin is frequently observed in malignant blood diseases and MPDs. An elevated level of plasma cobalamin is found in 30 to 50% of patients with Polycythemia Vera (PV). Objectives: the study aimed to: 1. Estimate JAK2 V617F mutation gene PV in Iraqi patients. 2. Measure the levels of IL-23 and B12 in the PV cases with JAK2V617F +ve mutation. Patients and Methods: Thirty patients were diagnosed as polycythaemia according to their clinical and laboratory findings like: CBC, and bone marrow biopsy (for some patients), liver and renal function test, abdominal U/S some with CT abdomen and JAK2 V617F mutation. Then levels of B12 and IL-23 were measured and correlated with CBC results. Results and Discussion: The mean age of PV patients was (52.0  12.5) with a range of (22-71 yrs), there was a PV case in a 22 years old male which was considered as a rare condition also male to female ratio of (1:1) is unusual. Splenomegaly and hepatomegaly present in 36.7% and 13.3% of PV patients respectively. The mean Hb was (17.2 1.7 g/dl), while the mean WBC count was (12.3±3.9 x109/L) and the platelet count was (446.0±285.2). Plasma levels of IL-23 were significantly increased in all patients with JAK2 V617F +ve mutation PV with mean (70.00±72.18 pg/mL) and range (8.5-259.0) and there was a significant positive correlation between IL-23 level and the total WBC count. B12 serum level was high in 16 of total 30 cases, with mean serum level (766.54±583.95pg/mL) .There was no Correlation between B12 level and Hb level, Platelet count and WBC count. Also there was no correlation between IL-23 and B12. Conclusions: 1. Study of JAK2V617F mutation is an important test in MPN patients, particularly in those who suspected to have PV. 2. The diagnosis of PV was based on clinical, haematological and genetic tests. While B.M. biopsy was not performed for the studied cases, it is recommended by WHO as a major criterion to establish a diagnosis of PV. (WHO criteria for PV diagnosis, 2016) 3. High levels of IL-23 in the sera of all PV patients that positively correlate with WBC count. 4. Cobalamin levels was elevated in 53.3% of PV.

PDF file: 

Editorial Board Member's

Dr.Geetanjali Joshi Mishra
Lucknow, UP, INDIA
Dr. Sankalp Verma
India
Tannu Arora
India
Prof Dr. Lee Mun Seng
Malaysia
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
Dr. Lim Gee Nee
Malaysia
DANA MOHAMMED
UK
Ali Majnoony Tootakhaneh
Iran
Prof. Somchai Amornyotin
Thailand
Nurhodja Akbulaev
Turkey
Muhammad Hamid
Pakistan
MOHAMMAD GHOLAMI
Iran
MAVLYANOV ISKANDAR RAKHIMOVICH
Uzbekistan
Hasan Ali Abed Al-Zu’bi
Jordan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Eapen, Asha Sarah
USA
Dr. Ruchika Khanna
India
DR. MUHAMMAD ISMAIL MOHMAND
UK
DR. MAHESH SHIVAJI CHAVAN
India
Dr. Lokesh Gambhir
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Charu Bisaria
India
Dr. Achmad Choerudin
Indonesia
Bensafi Abd-El-Hamid
Algeria
Dr. Pralhad Kanhaiyalal Rahangdale
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Arun Kumar
India
DR. M. ARUNA
India
ALIIHSAN SEKERTEKIN
Turkey
Yassine KADMI
French
Tariqual Islam Sajeeb
Dhaka
Jiban Shrestha
Nepal
Fredrick OJIJA
Tanzanian
Dr. Rasha Ali Eldeeb
Egypt
DR. PATRICK D. CERNA
Philippines
Dr. Amzad Basha Kolar
India
Prof. Suhail Hussein Al-Fatlawi
Iraq
ZiedIBN El Hadj
Tunisia
Zafer Omer Ozdemir
Turkey
Uthumporn Utra
Malasiya
Tarek Habeeb Ramadan Ahmed
Egypt
Syed Abdul Rehman Khan
China
Sri. P.C. Puri
India
Dr. Mohd Ramzi Bin Mohd Hussain
Malasiya
Peter Changilwa Kigwilu
Africa
P. Rajasulochana
India
Nam Nguyen Dang
Vietnam
Lachachi Abdelheq
Algerie
Ibrahim Khider Ibrahim Osman
Sudan
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Elsadig Gasoom FadelAlla Elbashir
Sudan
Dr. Zafar Iqbal
Pakistan
DR. Yogesh Dnyandeo Narkhede
India
Dr. Recep TAS
Turkey
Dr. Mustafa Y.G. Younis
Libiya
Dr. Ashok Kumar
India
Arshad Mehmood
Pakistan
Anania B. Aquino
Phillippines
Ahmed I.S. Ahmed
Egypt
Yaling Lin
Taiwan
Souhir Neifar
Tunisia
Nihad Abdel Latif Ali Kadhim
Iraq
Muhammad Aslam
Pakistan
Dr. Shahera S.Patel
India
Dr. Nicolas Padilla-Raygoza
Mexico
Dr. Jatinder Pal Singh Chawla
India
Dr. Devendra Kumar Gupta
India
Diones Krinski
Brasil
Aberham Kebedom Darge
Ethiopia
Atiya Firdous
Pakistan
Prof. Marco Nemesio E.Montano
Phillippines
Prof. Zora Singh
AUSTRALIA
Dr. Alaa Fahmy Mohamed
Egypt
Moataz Mostafa El-Nahas Ali El-sherbini
Egypt
Prof. M. Abdul Mottaleb
Maryville
Dr. Ali Seidi
Iran